Recording of Intraoperative Spinal Cord Stimulation and Monitoring
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Apr 28, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a technique called epidural electrical stimulation (EES) of the cervical spinal cord to see if it can help improve breathing in patients who are at risk of respiratory issues due to opioid use during surgery. Opioids are strong pain medications that can sometimes slow down breathing, which can be dangerous. By using EES during brain or spinal cord surgeries, researchers hope to find out if this stimulation can counteract the breathing problems caused by opioids, making surgery safer for patients.
To be eligible for this trial, patients need to be between the ages of 65 and 74 and must be undergoing surgery on the brain or spinal cord where spinal monitoring is used. There are no specific exclusions, meaning most patients in this category can participate. Those who join the study can expect to receive spinal cord stimulation during their surgery and will be monitored to see how it affects their respiratory function. This research could lead to important improvements in how patients are cared for during and after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patients undergoing brain or spinal cord surgery where spinal neuromonitoring is utilized.
- Exclusion Criteria:
- • none
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials